Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain - influence of levodopa treatment

Table 1 Number of MHC II ⁺ cells in the brain after tMCAO

MCAO Ipsilateral	MHC II⁺	MHC II⁺CD11b⁺	MHC II⁺CD11b⁺CD11c⁺
MCAO vh	2,732 ± 737	1,692 ± 540	36 ± 13
MCAO LD	3,693 ± 1,235	2,680 ± 1,060	77 ± 27
MCAO Contralateral	MHC II⁺	MHC II⁺CD11b⁺	MHC II⁺CD11b⁺CD11c⁺
MCAO vh	880 ± 215	650 ± 192	14 ± 4
MCAO LD	1,458 ± 462	1,048 ± 368	61 ± 25

Number of MHC II⁺ cells in brains from rats subjected to tMCAO for 105 minutes and treated either with saline (MCAO vh) or levodopa/benserazide (MCAO LD). Results are shown as absolute numbers ± SEM.

ISSN: 1742-2094